• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Logo
  • Home
  • Understanding KCNT1
  • Parents & Caregivers
    • Newly Diagnosed
    • Early-Onset KCNT1 Epilepsies
      • Medications for Early-Onset Epilepsies
    • Sleep-Related Hypermotor Epilepsy (SHE)
    • Symptoms & Treatments Overview
    • Treatment Approaches
    • Genetics 101
    • Life Expectancy & Long-Term Planning  
    • Financial & Caregiving Tools
    • Support & Resources
    • Sign Up for Our Parent Contact Form
    • Share Your KCNT1 Story
    • Find a Doctor
    • World Map (Census)
  • Professionals
    • Clinicians
    • Industry
    • Researchers
      • Biospecimens
      • KCNT1 Funding
      • Publications
  • Research & Clinical Trials
    • Parents & Caregivers
    • Clinical Trials
    • Clinical Trial Educational Resources
  • Support Us
    • Get Involved
    • Ways to Give
      • Shop our Store
      • Host a Fundraiser
  • About Us
    • Our Mission
    • Our Team
    • Our Advisors
    • Our Approach
    • Our Partners
    • Our Families
  • News & Events
    • FDA Patient Session
    • KCNT1 Remembering Day: October 21
    • News
    • Newsletter
    • KCNT1 in Orlando
    • Past Conferences
      • KCNT1 Anaheim Family Conf
      • Million Dollar Bike Ride
  • Contact
  • D♡nate

Our Mission

Support / Educational Resources / Research

Our Mission

Driving Urgent Progress for the KCNT1 Community

We unite families, researchers, and global partners to accelerate treatments and empower lives impacted by KCNT1-related epilepsy.

OUR MISSION

At the KCNT1 Epilepsy Foundation, the heart of our mission is to accelerate treatments for KCNT1-related epilepsy and neurodevelopmental disorders through biomarker discovery, collaborative research, and family empowerment. Founded by caregivers, we are driven by urgency, scientific integrity, and the belief that progress begins with connection.

Why Our Mission Matters

KCNT1-related epilepsy is a rare and devastating neurological disorder. It can cause early-onset seizures, regression, and severely limits developmental milestones. Most families have few treatment options—and no time to wait.

We’re here to change that.

540+

Families served globally

$200K+

Invested in mission-driven research

Research Driven by the Patient Voice

At the core of our research strategy is the belief that patients and caregivers are not just participants—they are partners. Our research priorities are shaped by the lived experiences of families in our network. Parent-led insights guide our funding decisions, ensuring that every project we support is aligned with real-world needs and urgent family goals. We regularly consult our Family Network, involve caregivers in strategic discussions, and prioritize funding research that addresses quality of life, symptom relief, and clinical readiness.

Our Strategic Priorities

  • Identify biomarkers & build data for trials
  • Develop global care guidelines
  • Expand family outreach & diagnostics
  • Fund translational research
  • Strengthen biotech & research collaborations
  • Provide educational materials for those with KCNT1 gene variants

Stewardship with Integrity

“At KCNT1 Epilepsy Foundation, we don’t just fund ideas—we invest in real progress.”

  • Independent Scientific Reviews
  • Milestone-based funding
  • Transparent reporting and accountability

Join Us in Creating Change

We believe that patients and families are essential partners in progress. Your voice, your experience, and your support help guide our research, advocacy, and education initiatives.

Join the Movement

Support the Mission

Sponsor a Program

Footer

fluid-image
Donate Today
  • Parents & Caregivers
  • Researchers & Professionals
  • About Us
  • Contact
  • Subscribe
Gold 2025 Candid Seal
GAA Member Badge
Citizen Health Proud Partner 2025 Website Badge

Privacy Policy

© 2023 KCNT1 Epilepsy Foundation | All Rights Reserved | Disclaimer

EIN 84-2748218

Copyright © 2026